Literature DB >> 9630749

Muscle-specific cell ablation conditional upon Cre-mediated DNA recombination in transgenic mice leads to massive spinal and cranial motoneuron loss.

U Grieshammer1, M Lewandoski, D Prevette, R W Oppenheim, G R Martin.   

Abstract

We describe here a binary transgenic system based on Cre-mediated DNA recombination for genetic cell ablation in mice that enabled us to obtain skeletal muscle-deficient embryos by mating two phenotypically normal transgenic lines. In those embryos, skeletal muscles are eliminated as a consequence of the expression of the gene encoding the diphtheria toxin A fragment. Cell ablation occurs gradually beginning approximately on embryonic day (E) 12.5, and by E18-5 almost all skeletal muscle is absent. Analysis of the consequences of muscle cell ablation revealed that almost all spinal motoneurons are lost by E18.5, providing strong evidence that survival of spinal motoneurons during embryogenesis is dependent on signals from their target tissue, skeletal muscle, and that trophic signals produced by nonmuscle sources are sufficient to support survival of no more than 10% of embryonic spinal motoneurons in the absence of muscle-derived signals. There was also substantial loss of cranial (hypoglossal and facial) motoneurons in the muscle-deficient embryos, thus indicating that cranial motoneuron survival is also dependent on trophic signals produced by their target tissue. Although spinal motoneurons are a major target of spinal interneurons, the loss of motoneurons did not affect interneuron survival. Muscle-deficient embryos had a cleft palate and abnormalities of the lower jaw, raising the possibility that they might serve as a mouse model for the human disorder, Robin sequence. The data reported here demonstrate the utility of a binary transgenic system for obtaining mouse embryos in which a specific cell population has been ablated, so that its role in embryonic development can be studied.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630749     DOI: 10.1006/dbio.1997.8859

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  28 in total

Review 1.  Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.

Authors:  Lee J Martin; Qing Chang
Journal:  Mol Neurobiol       Date:  2011-11-10       Impact factor: 5.590

2.  Astrocyte and muscle-derived secreted factors differentially regulate motoneuron survival.

Authors:  Anna R Taylor; David J Gifondorwa; Jason M Newbern; Mac B Robinson; Jane L Strupe; David Prevette; Ronald W Oppenheim; Carolanne E Milligan
Journal:  J Neurosci       Date:  2007-01-17       Impact factor: 6.167

Review 3.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

4.  Axon and muscle spindle hyperplasia in the myostatin null mouse.

Authors:  Mohamed I Elashry; Anthony Otto; Antonios Matsakas; Salah E El-Morsy; Lisa Jones; Bethan Anderson; Ketan Patel
Journal:  J Anat       Date:  2011-02       Impact factor: 2.610

5.  Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons.

Authors:  R W Oppenheim; S Wiese; D Prevette; M Armanini; S Wang; L J Houenou; B Holtmann; R Gotz; D Pennica; M Sendtner
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

6.  Novel combinatorial screening identifies neurotrophic factors for selective classes of motor neurons.

Authors:  Sébastien Schaller; Dorothée Buttigieg; Alysson Alory; Arnaud Jacquier; Marc Barad; Mark Merchant; David Gentien; Pierre de la Grange; Georg Haase
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-07       Impact factor: 11.205

7.  Prdm16 is required for normal palatogenesis in mice.

Authors:  Bryan C Bjork; Annick Turbe-Doan; Mary Prysak; Bruce J Herron; David R Beier
Journal:  Hum Mol Genet       Date:  2009-12-11       Impact factor: 6.150

8.  Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis.

Authors:  G Yacila; Y Sari
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

9.  Myocardial deletion of Smad4 using a novel α skeletal muscle actin Cre recombinase transgenic mouse causes misalignment of the cardiac outflow tract.

Authors:  Mohamad Azhar; Pei-Yu Wang; Tony Frugier; Kyoko Koishi; Chuxia Deng; Peter G Noakes; Ian S McLennan
Journal:  Int J Biol Sci       Date:  2010-09-20       Impact factor: 6.580

10.  Cell depletion due to diphtheria toxin fragment A after Cre-mediated recombination.

Authors:  Damian Brockschnieder; Corinna Lappe-Siefke; Sandra Goebbels; Michael R Boesl; Klaus-Armin Nave; Dieter Riethmacher
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.